(Q46535726)

English

Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladder

scientific article published in September 2005

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16096831

Efficacy and tolerability of darifenacin, a muscarinic M3 selective receptor antagonist (M3 SRA), compared with oxybutynin in the treatment of patients with overactive bladder (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16096831

0 references

author name string

Norman Zinner

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16096831

John Tuttle

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16096831

Leonard Marks

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16096831

publication date

1 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16096831

World Journal of Urology

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16096831

23

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16096831

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16096831

248-252

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16096831

https://scigraph.springernature.com/pub.10.1007/s00345-005-0507-3

0 references

Oxybutynin and cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS00345-005-0507-3

21 January 2018

Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride

1 reference

https://api.crossref.org/works/10.1007%2FS00345-005-0507-3

21 January 2018

Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of cognitive function of the elderly population: effects of darifenacin

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and burden of overactive bladder in the United States

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The overactive bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immediate-release oxybutynin versus tolterodine in detrusor overactivity: a population analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Muscarinic acetylcholine receptor subtypes mediating urinary bladder contractility and coupling to GTP binding proteins.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

M(3) muscarinic receptors mediate contraction of human urinary bladder

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The minor population of M3-receptors mediate contraction of human detrusor muscle in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Transient memory impairment and hallucinations associated with tolterodine use.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A medium-term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overactive bladder significantly affects quality of life.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tolterodine and memory: dry but forgetful

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology of lower urinary tract smooth muscles and penile erectile tissues.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety profile of tolterodine as used in general practice in England: results of prescription-event monitoring

1 reference

https://pubmed.ncbi.nlm.nih.gov/16096831

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00345-005-0507-3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16096831

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/16096831

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46535726&oldid=2116907974"